APPARENT MINERALOCORTICOID EXCESS IN THREE SIBLINGS

Authors

  • JANOS HOMOKI the Dept. of Biochemistry, Ulm University, Ulm, Germany
  • MARYAM RAZZAGHY-AZAR From the Dept. of Pediatrics, Hazrat Aliasghar Children's Hospital, lran University of Medical Sciences
Abstract:

Three siblings (1 boy, 2 girls) with hypertension and hypokalemia are presented, two with low plasma aldosterone and suppressed renin activity and the eldest with a high renin and aldosterone level due to secondary changes in her kidneys. Urinary tetrahydrocortisol (THF) was increased relative to tetrahydrocortisone (THE). Cortisol ring A reduction constant was also lower than normal. These findings are suggestive of decreased cortisol-II β-hydroxysteroid dehydrogenase activity and ring A reduction defect which has previously been described in type 1 apparent mineralocorticoid excess.1 The existence of this disease in three siblings from healthy parents with consanguinous marriage reveals the genetic (autosomal recessive) nature of the disease. Spironolactone normalized serum potassium in all three patients and hypertension in two of them. Furosemide and captopril were required for lowering blood pressure in the eldest one. Treatment caused growth catch up in all three patients

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

apparent mineralocorticoid excess in three siblings

three siblings (1 boy, 2 girls) with hypertension and hypokalemia are presented, two with low plasma aldosterone and suppressed renin activity and the eldest with a high renin and aldosterone level due to secondary changes in her kidneys. urinary tetrahydrocortisol (thf) was increased relative to tetrahydrocortisone (the). cortisol ring a reduction constant was also lower than normal. these fin...

full text

Syndrome of Apparent Mineralocorticoid Excess

The first adult case of 1 1,-hydroxysteroid dehydrogenase ( 1#6-OHSD) deficiency is described. The impaired conversion of cortisol to cortisone (indicated by urinary cortisol and cortisone metabolites and failure to metabolize 1 a-VIHlcortisol to 13H1H20), was associated with hypertension, hypokalemia, and suppression of the renin-angiotensin-aldosterone system. When established on a fixed Na+/...

full text

Apparent mineralocorticoid excess (AME) syndrome.

Apparent mineralocorticoid excess (AME) syndrome is a rare autosomal recessive disorder due to the deficiency of 11b hydroxysteroid dehydrogenase type 2 enzyme (11beta-HSD2). Mutations in this gene affect the enzymatic activity resulting to an excess of cortisol, which causes its inappropriate access to mineralocorticoid receptor leading to inherited hypertension.This is a potentially fatal but...

full text

Apparent mineralocorticoid excess syndrome: an overview.

Apparent mineralocorticoid excess (AME) syndrome results from defective 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2). This enzyme is co-expressed with the mineralocorticoid receptor (MR) in the kidney and converts cortisol (F) to its inactive metabolite cortisone (E). Its deficiency allows the unmetabolized cortisol to bind to the MR inducing sodium retention, hypokalemia, suppressi...

full text

The syndrome of apparent mineralocorticoid excess.

The elucidation of the basis of a rare inherited dis-development of hypertension, the biochemical abnormalities and the disturbances in cortisol meta-order is satisfying in itself, but particularly so if it leads to a greater understanding of normal physiology bolism.7 How then could cortisol, conventionally regarded as a glucocorticoid, act as a potent mineral-and other disease processes. Such...

full text

A switch in the mechanism of hypertension in the syndrome of apparent mineralocorticoid excess.

The syndrome of apparent mineralocorticoid excess arises from nonfunctional mutations in 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2), an enzyme that inactivates cortisol and confers aldosterone specificity on the mineralocorticoid receptor. Loss of 11betaHSD2 permits glucocorticoids to activate the mineralocorticoid receptor, and the hypertension in the syndrome is presumed to arise...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 10  issue 3

pages  249- 254

publication date 1996-11

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023